Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAI Oxaliplatin with FOLFIRI and Bevacizumab for CRLM
NCT04003792Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Jan 2020
- Primary completion
- Jan 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in Colorectal cancer with liver metastases (CRLM), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT04003792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003792.